Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Colon Capsule Endoscopy Boosters in High-Risk Colorectal Polyp Patients
2016-002237-30Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Jul 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in colonic polyp and colorectal cancer (CRC) comparing Moviprep booster arm, Eziclen booster arm and Gastrografin booster arm (3 arms). Primary endpoint: Colon capsule excretion. Started Jul 2016; status: completed.
02
Drugs
macrogolsodium sulfate + potassium sulfate + magnesium sulfatediatrizoate meglumine + diatrizoate sodium
03
Conditions
colonic polypcolorectal cancer (CRC)
Beyond the preview
Go deeper on 2016-002237-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002237-30.